Boston Heart Diagnostics 

What is the Boston Heart Test?

Boston Heart is transforming the treatment of cardiovascular disease by providing healthcare providers and their patients with novel, personalized diagnostics and reports with integrated, customized lifestyle programs that have the power to change the way clinicians and patients communicate about disease and improve heart health.  Doctors Directs' Dr. Derek Murphy is one of these healthcare providers that personalizes his care for his patients. He has forever supported his patients taking control of their healthcare.  With Boston Heart there exists another way to incorporate academic knowledge into everyday lifestyle. The Boston Heart Lifestyle Program is different from others that you might have seen or tried. With Boston Heart, you get personalized recommendations for improving your daily habits, which are linked to proven scientific research into how to improve heart health and your health in general.  This is personalized information for you!  Additionally, you get the support of trained, caring coaches, who are Registered Dietitians and will help you get going—and keep going—toward your goals. Excerpt in part from Boston Heart website.

Reduce your Cardiovascular Risk

Boston Heart HDL Map Test 

Boston Heart Cholesterol Balance

  • Increased amounts of large α-mobility HDL particles are associated with healthy HDL maturation and decreased cardiovascular disease risk. High levels of α-1 HDL are a marker of protection from heart disease.

  • Increased amounts of small HDL particles are associated with a deficiency in HDL maturation and increased CVD risk. High levels of the very small preβ-1 and small α-3 and α-4 HDL particles are markers of high risk for the presence of clinical or subclinical cardiovascular disease. 

Knowing how an individual produces and absorbs cholesterol can help determine the most effective LDL-C lowering therapy. Understanding in advance which therapy will have the greatest efficacy allows for a more successful and cost-effective CVD treatment strategy.

Plant sterols found in the plasma, beta-sitosterol and campesterol, are direct measures of cholesterol absorption. Individuals who over-absorb cholesterol in the intestine have elevated levels of these markers. Decreased values, which reflect low cholesterol absorption, are optimal. Elevated levels are associated with:
  • Increased cholesterol absorption and elevated LDL-C levels;
  • Increased risk of CVD independent of LDL-C, as shown in both PROCAM (Assmann et al. 2006) and the Framingham Heart Study (Matthan et al. 2009);
  • Lack of clinical benefit from simvastatin, as shown in the 4S Study (Miettinen et al. 1998); and,
  • Mutation in genes encoding ABCG5 and ABCG8, in patients with marked elevations of plant sterols and premature heart disease.

(Boston Heart Diagnostics, 2016)